510(k) K061376
K061376 is an FDA 510(k) premarket notification submitted by Theratest Laboratories, Inc. for the device "EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3". The FDA issued a decision of Substantially Equivalent on Jul 20, 2006. The device falls under product code MOB (Test System, Antineutrophil Cytoplasmic Antibodies (Anca)), a Class II device regulated under 21 CFR 866.5660. Theratest Laboratories, Inc. has 21 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 20, 2006
- Date Received
- May 17, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Theratest Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.